Tyra Biosciences IPO

Tyra Biosciences targets resistance in oncology with purpose built drugs for the benefit of patients.

Register for Details

For more details on financing and valuation for Tyra Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Tyra Biosciences's ticker symbol?


What is Tyra Biosciences's stock price?

13.76 as of 6/1/23

Tyra Biosciences Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/31/2021 Series B $106.3MM raised $XXX.XX $XXX.XX
1/10/2020 Series A $51.34MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Tyra Biosciences

Forge green plus iconForge green minus icon

What is Tyra Biosciences funding to date?

Tyra Biosciences has raised $157.64MM with the following series:
$51.34MM raised for Series A,$106.3MM raised for Series B.
Forge green plus iconForge green minus icon

When was Tyra Biosciences founded?

Tyra Biosciences was founded in 2018.
Updated on: Jun 12, 2022